Epstein-Barr virus-positive and -negative B-cell lines can be infected with human immunodeficiency virus types 1 and 2
- PMID: 2841499
- PMCID: PMC253476
- DOI: 10.1128/JVI.62.9.3497-3500.1988
Epstein-Barr virus-positive and -negative B-cell lines can be infected with human immunodeficiency virus types 1 and 2
Abstract
Human immunodeficiency virus type 1 (HIV-1) can infect CD4+ lymphocytes, monocytes-macrophages, and various other cell lines, including B-cell lines. To study the parameters of B-cell infections, we examined the susceptibility of 24 B-lymphoid cell lines to both HIV-1 and HIV-2 infections. These cell lines included a series of Epstein-Barr virus (EBV) genome-negative Burkitt's lymphoma cell lines and their EBV-converted counterparts. To infect these cells we used two HIV-1 isolates and one HIV-2 isolate. Infections were monitored with a cytoplasmic RNA dot-blot and a syncytium assay. HIV infection was also studied by a novel method based on electrophoresis of DNA liberated from cells that were lysed in situ in the well of an agarose gel. All human B-cell lines could be infected with HIV-1, regardless of the presence of EBV genomes; thus, EBV infection had no major effect on HIV susceptibility of B-cell lines. Integrated proviral HIV genomes could be detected by Southern blot analysis of DNA extracted from long-term, non-HIV-producing B-cell lines. This study suggests that B-lymphoid cells may serve as reservoirs for latent or persistent HIV infections in vivo, even in the absence of EBV infection.
Similar articles
-
Synergy between human immunodeficiency virus type 1 and Epstein-Barr virus in T lymphoblastoid cell lines.AIDS Res Hum Retroviruses. 1997 Jan 20;13(2):161-71. doi: 10.1089/aid.1997.13.161. AIDS Res Hum Retroviruses. 1997. PMID: 9007201
-
Human immunodeficiency virus activates c-myc and Epstein-Barr virus in human B lymphocytes.Ann N Y Acad Sci. 1992 May 4;651:422-32. doi: 10.1111/j.1749-6632.1992.tb24642.x. Ann N Y Acad Sci. 1992. PMID: 1318011
-
Different patterns of Epstein-Barr virus gene expression and of cytotoxic T-cell recognition in B-cell lines infected with transforming (B95.8) or nontransforming (P3HR1) virus strains.J Virol. 1988 Mar;62(3):894-901. doi: 10.1128/JVI.62.3.894-901.1988. J Virol. 1988. PMID: 2828684 Free PMC article.
-
Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?Adv Cancer Res. 2000;79:175-200. doi: 10.1016/s0065-230x(00)79006-3. Adv Cancer Res. 2000. PMID: 10818681 Review.
-
Epstein-Barr virus: a human pathogen inducing lymphoproliferation in vivo and in vitro.Rev Infect Dis. 1982 Sep-Oct;4(5):1048-61. doi: 10.1093/clinids/4.5.1048. Rev Infect Dis. 1982. PMID: 6293034 Review.
Cited by
-
Effect of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine on establishment of human immunodeficiency virus type 1 infection in cultured CD8+ lymphocytes.Antimicrob Agents Chemother. 1994 May;38(5):986-90. doi: 10.1128/AAC.38.5.986. Antimicrob Agents Chemother. 1994. PMID: 8067781 Free PMC article.
-
In vivo lymphocyte tropism of feline immunodeficiency virus.J Virol. 1993 Sep;67(9):5175-86. doi: 10.1128/JVI.67.9.5175-5186.1993. J Virol. 1993. PMID: 7688819 Free PMC article.
-
EBV renders B cells susceptible to HIV-1 in humanized mice.Life Sci Alliance. 2020 Jun 23;3(8):e202000640. doi: 10.26508/lsa.202000640. Print 2020 Aug. Life Sci Alliance. 2020. PMID: 32576602 Free PMC article.
-
Human immunodeficiency virus pseudotypes with expanded cellular and species tropism.J Virol. 1990 May;64(5):2298-308. doi: 10.1128/JVI.64.5.2298-2308.1990. J Virol. 1990. PMID: 1691314 Free PMC article.
-
Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity.J Virol. 1992 Nov;66(11):6496-501. doi: 10.1128/JVI.66.11.6496-6501.1992. J Virol. 1992. PMID: 1404600 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials